Androgen receptor-mediated repression of novel _target genes
- PMID: 17624924
- DOI: 10.1002/pros.20623
Androgen receptor-mediated repression of novel _target genes
Abstract
Background: The androgen receptor (AR) plays a pivotal role in prostate cancer (PCa) initiation and progression. To date, studies have focused disproportionately on androgen-stimulated genes such as prostate-specific antigen (PSA), while repressed genes have gained little attention, even though they too may be involved in regulating cell growth, differentiation, and apoptosis.
Methods: ChIP Display was used to identify putative AR _target genes in the ablation-resistant human PCa cell line, C4-2B. Quantitative real-time reverse transcription-PCR analysis was used to measure gene expression in cells subjected to dihydrotestosterone (DHT) timecourse and dose-response, as well as AR knock-down and bicalutamide-treatments.
Results: We report on three genes, KIAA1217, CHRM1, and WBSCR28, which were newly identified in a screen for AR-occupied regions in C4-2B PCa cells, and which were repressed by treatment with DHT. AR knock-down resulted in increased KIAA1217, CHRM1, and WBSCR28 mRNA, indicating that, like PSA stimulation, AR represses these three genes even in the absence of added ligand. DHT decreased KIAA1217 and CHRM1 pre-mRNA levels, suggesting AR-mediated transcriptional inhibition. Cycloheximide attenuated DHT-mediated repression of CHRM1, suggesting the requirement of new protein synthesis. Furthermore, bicalutamide treatment did not mimic, but rather antagonized DHT-mediated KIAA1217 repression. Unlike the handful of androgen-repressed genes studied thus far, AR occupancy at KIAA1217, CHRM1, and WBSCR28 was mapped outside their respective 5'-promoter regions.
Conclusions: Many more genes likely share AR-mediated gene repression through distal regulatory elements. Further study of such _targets and their transcriptional regulation may help explain the receptor's tumorigenicity in PCa.
2007 Wiley-Liss, Inc
Similar articles
-
Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.Cancer Res. 2000 Oct 15;60(20):5825-31. Cancer Res. 2000. PMID: 11059779
-
Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.Prostate. 2008 May 15;68(7):793-801. doi: 10.1002/pros.20748. Prostate. 2008. PMID: 18324645
-
Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.Prostate. 2007 May 15;67(7):722-31. doi: 10.1002/pros.20565. Prostate. 2007. PMID: 17342749
-
Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.J Cell Biochem. 2005 Jul 1;95(4):657-69. doi: 10.1002/jcb.20460. J Cell Biochem. 2005. PMID: 15861399 Review.
-
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.Eur Urol. 1997;32 Suppl 3:24-40. Eur Urol. 1997. PMID: 9267783 Review.
Cited by
-
Cooperation between Polycomb and androgen receptor during oncogenic transformation.Genome Res. 2012 Feb;22(2):322-31. doi: 10.1101/gr.131508.111. Epub 2011 Dec 16. Genome Res. 2012. PMID: 22179855 Free PMC article.
-
Identification of novel androgen receptor _target genes in prostate cancer.Mol Cancer. 2007 Jun 6;6:39. doi: 10.1186/1476-4598-6-39. Mol Cancer. 2007. PMID: 17553165 Free PMC article.
-
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis.EMBO J. 2011 May 20;30(13):2719-33. doi: 10.1038/emboj.2011.158. EMBO J. 2011. PMID: 21602788 Free PMC article.
-
Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer.Asian J Androl. 2019 May-Jun;21(3):215-223. doi: 10.4103/aja.aja_19_19. Asian J Androl. 2019. PMID: 30950412 Free PMC article. Review.
-
Integrin signalling adaptors: not only figurants in the cancer story.Nat Rev Cancer. 2010 Dec;10(12):858-70. doi: 10.1038/nrc2967. Epub 2010 Nov 24. Nat Rev Cancer. 2010. PMID: 21102636 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous